The antimicrobial skin barrier in patients with atopic dermatitis

Current Problems in Dermatology

Volumn 41, Issue , 2011, Pages 54-67

  Schittek, Birgit ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ANTIINFECTIVE AGENT; CHEMOKINE; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CELL POPULATION; CYTOKINE PRODUCTION; DATA ANALYSIS; DISEASE PREDISPOSITION; EPITHELIUM; HUMAN; INFECTION; INNATE IMMUNITY; KERATINOCYTE; MEDICAL RECORD; MICROORGANISM; NONHUMAN; PATHOGENESIS; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PSORIASIS; SKIN DEFECT; SKIN INFECTION; SKIN PERMEABILITY; STAPHYLOCOCCUS AUREUS;

ANTIMICROBIAL CATIONIC PEPTIDES; DERMATITIS, ATOPIC; HUMANS; IMMUNITY, INNATE; KERATINOCYTES; MODELS, BIOLOGICAL; PERMEABILITY; SKIN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 79958056355     PISSN: 14215721     EISSN: 16622944     Source Type: Book Series    
DOI: 10.1159/000323296     Document Type: Article

References (112)

1. Schittek B, Paulmann M, Senyurek I, Steffen H: The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets 2008;8:135-143.
2. Harder J, Schroder JM: Antimicrobial peptides in human skin. Chem Immunol Allergy 2005;86: 22-41. (Pubitemid 40904996)
3. Schröer JM, Harder J: Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006;63:469-486.
4. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ: Skin immune sentinels in health and disease. Nat Rev Immunol 2009;9:679-691.
5. Lebre MC, van der Aar AM, van Baarsen L, van Capel TM, Schuitemaker JH, Kapsenberg ML, de Jong EC: Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol 2007;127:331-341. (Pubitemid 46106911)
6. Wanke I, Steffen H, Christ C, Krismer B, Gotz F, Peschel A, Schaller M, Schittek B: Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol 2010, E-pub ahead of print.
7. Kollisch G, Kalali BN, Voelcker V, Wallich R, Behrendt H, Ring J, Bauer S, Jakob T, Mempel M, Ollert M: Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 2005; 114:531-541. (Pubitemid 40478147)
8. Terhorst D, Kalali BN, Ollert M, Ring J, Mempel M: The role of Toll-like receptors in host defenses and their relevance to dermatologic diseases. Am J Clin Dermatol 2010;11:1-10.
9. Kalali BN, Kollisch G, Mages J, Muller T, Bauer S, Wagner H, Ring J, Lang R, Mempel M, Ollert M: Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling. J Immunol 2008;181:2694-2704.
10. Miller LS, Modlin RL: Human keratinocyte Toll-like receptors promote distinct immune responses. J Invest Dermatol 2007;127:262-263. (Pubitemid 46106899)
11. Albanesi C, Scarponi C, Giustizieri ML, Girolomoni G: Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 2005;4: 329-334. (Pubitemid 40873120)
12. Homey B: Chemokines and inflammatory skin diseases. Adv Dermatol 2005;21:251-277. (Pubitemid 41826754)
13. Purwar R, Wittmann M, Zwirner J, Oppermann M, Kracht M, Dittrich-Breiholz O, Gutzmer R, Werfel T: Induction of C3 and CCL2 by C3a in keratinocytes: a novel autocrine amplification loop of inflammatory skin reactions. J Immunol 2006;177: 4444-4450. (Pubitemid 44469773)
14. Wittmann M, Werfel T: Interaction of keratinocytes with infiltrating lymphocytes in allergic eczematous skin diseases. Curr Opin Allergy Clin Immunol 2006;6:329-334. (Pubitemid 44368238)
15. Boman HG: Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 1995;13: 61-92.
16. Zasloff M: Antimicrobial peptides in health and disease. N Engl J Med 2002;347:1199-1200.
17. Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI: Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 1998;42:2206-2214. (Pubitemid 28420351)
18. Di Nardo A, Vitiello A, Gallo RL: Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 2003;170:2274-2278. (Pubitemid 36245611)
19. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jornvall H, Wigzell H, Gudmundsson GH: The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000;96:3086-3093.
20. Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, Schirle M, Schroeder K, Blin N, Meier F, Rassner G, Garbe C: Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol 2001;2:1133-1137. (Pubitemid 33130147)
21. Rieg S, Garbe C, Sauer B, Kalbacher H, Schittek B: Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol 2004;151:534-539. (Pubitemid 39330875)
22. Rieg S, Seeber S, Steffen H, Humeny A, Kalbacher H, Stevanovic S, Kimura A, Garbe C, Schittek B: Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites. J Invest Dermatol 2006;126:354-365. (Pubitemid 43323171)
23. Muller FB, Muller-Rover S, Korge BP, Kapas S, Hinson JP, Philpott MP: Adrenomedullin: expression and possible role in human skin and hair growth. Br J Dermatol 2003;148:30-38. (Pubitemid 36114858)
24. Lee DY, Yamasaki K, Rudsil J, Zouboulis CC, Park GT, Yang JM, Gallo RL: Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill Propionibacterium acnes. J Invest Dermatol 2008;128:1863-1866. (Pubitemid 351847367)
25. Nagy I, Pivarcsi A, Kis K, Koreck A, Bodai L, McDowell A, Seltmann H, Patrick S, Zouboulis CC, Kemeny L: Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 2006;8: 2195-2205. (Pubitemid 44335873)
26. Harder J, Glaser R, Schroder JM: The role and potential therapeutical applications of antimicrobial proteins in infectious and inflammatory diseases. Endocr Metab Immune Disord Drug Targets 2007;7: 75-82. (Pubitemid 46965217)
27. Fulton C, Anderson GM, Zasloff M, Bull R, Quinn AG: Expression of natural peptide antibiotics in human skin. Lancet 1997;350:1750-1751. (Pubitemid 28036680)
28. Glaser R, Meyer-Hoffert U, Harder J, Cordes J, Wittersheim M, Kobliakova J, Folster-Holst R, Proksch E, Schroder JM, Schwarz T: The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 2009;129: 641-649.
29. Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM: Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005;6:57-64. (Pubitemid 40136696)
30. Yamasaki K, Gallo RL: Antimicrobial peptides in human skin disease. Eur J Dermatol 2008;18: 11-21. (Pubitemid 351158166)
31. Bals R: Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000;1: 141-150.
32. Medzhitov R, Janeway CJ: Innate immunity. N Engl J Med 2000;343:338-344.
33. Namjoshi S, Caccetta R, Benson HA: Skin peptides: biological activity and therapeutic opportunities. J Pharm Sci 2008;97:2524-2542.
34. Tosi MF: Innate immune responses to infection. J Allergy Clin Immunol 2005;116:241-249. (Pubitemid 41096524)
35. Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, Schroder JM: Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human betadefensin- 2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000;22:714-721. (Pubitemid 30400251)
36. Harder J, Meyer-Hoffert U, Wehkamp K, Schwichtenberg L, Schroder JM: Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 2004;123:522-529. (Pubitemid 39095623)
37. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi- Joannopoulos K, Collins M, Fouser LA: Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006;203:2271-2279. (Pubitemid 44498362)
38. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K, Volk HD, Sterry W, Sabat R: IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006;36:1309-1323.
39. Kisich KO, Howell MD, Boguniewicz M, Heizer HR, Watson NU, Leung DY: The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol 2007;127:2368-2380. (Pubitemid 47619743)
40. Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N: Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003;170:5583-5589. (Pubitemid 36617848)
41. Menzies BE, Kenoyer A: Staphylococcus aureus infection of epidermal keratinocytes promotes expression of innate antimicrobial peptides. Infect Immun 2005;73:5241-5244. (Pubitemid 41105689)
42. Midorikawa K, Ouhara K, Komatsuzawa H, Kawai T, Yamada S, Fujiwara T, Yamazaki K, Sayama K, Taubman MA, Kurihara H, Hashimoto K, Sugai M: Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun 2003;71:3730-3739. (Pubitemid 36753693)
43. Abtin A, Eckhart L, Mildner M, Gruber F, Schroder JM, Tschachler E: Flagellin is the principal inducer of the antimicrobial peptide S100A7c (psoriasin) in human epidermal keratinocytes exposed to Escherichia coli. FASEB J 2008;22:2168-2176. (Pubitemid 351948636)
44. Weaver CT, Hatton RD, Mangan PR, Harrington LE: IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-852. (Pubitemid 46697925)
45. Kolls JK, McCray PB Jr, Chan YR: Cytokinemediated regulation of antimicrobial proteins. Nat Rev Immunol 2008;8:829-835.
46. Sorensen OE, Thapa DR, Roupe KM, Valore EV, Sjobring U, Roberts AA, Schmidtchen A, Ganz T: Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 2006;116: 1878-1885. (Pubitemid 44033312)
47. Sorensen OE, Thapa DR, Rosenthal A, Liu L, Roberts AA, Ganz T: Differential regulation of beta-defensin expression in human skin by microbial stimuli. J Immunol 2005;174:4870-4879.
48. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH: Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004;173:2909-2912. (Pubitemid 39141992)
49. Weber G, Heilborn JD, Chamorro Jimenez CI, Hammarsjo A, Torma H, Stahle M: Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 2005;124:1080-1082. (Pubitemid 40629115)
50. Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Kiken D, Helfrich YR, Kang S, Elalieh HZ, Steinmeyer A, Zugel U, Bikle DD, Modlin RL, Gallo RL: Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 2007;117: 803-811. (Pubitemid 46348539)
51. Heilborn JD, Weber G, Gronberg A, Dieterich C, Stahle M: Topical treatment with the vitamin D analogue calcipotriol enhances the upregulation of the antimicrobial protein hCAP18/LL-37 during wounding in human skin in vivo. Exp Dermatol 2010;19:332-338.
52. Bernard JJ, Gallo RL: Cyclooxygenase-2 enhances antimicrobial peptide expression and killing of Staphylococcus aureus. J Immunol 2010;185: 6535-6544.
53. Menzies BE, Kenoyer A: Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytes. Infect Immun 2006;74:6847-6854. (Pubitemid 44913160)
54. Zanger P, Holzer J, Schleucher R, Steffen H, Schittek B, Gabrysch S: Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. J Infect Dis 2009;200:1907-1915.
55. Simanski M, Dressel S, Glaser R, Harder J: RNase 7 protects healthy skin from Staphylococcus aureus colonization. J Invest Dermatol 2010;130:2836-2838.
56. Zanger P, Holzer J, Schleucher R, Scherbaum H, Schittek B, Gabrysch S: Severity of Staphylococcus aureus infection of the skin is associated with inducibility of human beta-defensin 3 but not human beta-defensin 2. Infect Immun 2010;78:3112-3117.
57. Cogen AL, Yamasaki K, Muto J, Sanchez KM, Crotty AL, Tanios J, Lai Y, Kim JE, Nizet V, Gallo RL: Staphylococcus epidermidis antimicrobial deltatoxin (phenol-soluble modulin-gamma) cooperates with host antimicrobial peptides to kill group A Streptococcus. PLoS One 2010;5:e8557.
58. Lai Y, Di Nardo A, Nakatsuji T, Leichtle A, Yang Y, Cogen AL, Wu ZR, Hooper LV, Schmidt RR, von Aulock S, Radek KA, Huang CM, Ryan AF, Gallo RL: Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 2009;15:1377-1382.
59. Chung WO, Dale BA: Differential utilization of nuclear factor-kappaB signaling pathways for gingival epithelial cell responses to oral commensal and pathogenic bacteria. Oral Microbiol Immunol 2008; 23:119-126. (Pubitemid 351248606)
60. Chung WO, Dale BA: Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect Immun 2004;72:352-358. (Pubitemid 38018195)
61. Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, Ryan AF, Di Nardo A, Gallo RL: Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol 2010;130:2211-2221.
62. Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M: Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci USA 2007;104:9469-9474. (Pubitemid 47185803)
63. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M: The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 2007;66:1136-1147. (Pubitemid 350115022)
64. Biedermann T: Dissecting the role of infections in atopic dermatitis. Acta Derm Venereol 2006;86: 99-109. (Pubitemid 44020173)
65. Aly R, Maibach HI, Shinefield HR: Microbial flora of atopic dermatitis. Arch Dermatol 1977;113: 780-782. (Pubitemid 8131178)
66. Leyden JJ, Marples RR, Kligman AM: Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90:525-530.
67. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA: New insights into atopic dermatitis. J Clin Invest 2004;113:651-657. (Pubitemid 38544154)
68. Novak N, Bieber T, Leung DY: Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003;112:S128-S139. (Pubitemid 37550029)
69. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM: pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003;121:345-353. (Pubitemid 36969909)
70. Elias PM, Schmuth M: Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 2009;9:437-446.
71. Sator PG, Schmidt JB, Honigsmann H: Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 2003;48:352-358. (Pubitemid 36337071)
72. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, Di Giovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH: Common lossof- function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38:441-446.
73. O'Regan GM, Sandilands A, McLean WH, Irvine AD: Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2009;124:R2-R6.
74. Henderson J, Northstone K, Lee SP, Liao H, Zhao Y, Pembrey M, Mukhopadhyay S, Smith GD, Palmer CN, McLean WH, Irvine AD: The burden of disease associated with filaggrin mutations: a populationbased, longitudinal birth cohort study. J Allergy Clin Immunol 2008;121:872-877.
75. Niebuhr M, Werfel T: Innate immunity, allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 2010;10:463-468.
76. Imokawa G: Skin moisturizers: development and clinical use of ceramides; in Loden M (ed): Dry Skin and Moisturizers. Boca Raton, CRC Press, 1999, pp 269-299.
77. Hatano Y, Man MQ, Uchida Y, Crumrine D, Scharschmidt TC, Kim EG, Mauro TM, Feingold KR, Elias PM, Holleran WM: Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis. J Invest Dermatol 2009; 129:1824-1835.
78. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA: Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 2009; 129:14-30.
79. Baker BS: The role of microorganisms in atopic dermatitis. Clin Exp Immunol 2006;144:1-9.
80. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003;171:3262-3269. (Pubitemid 37093553)
81. Elias PM, Feingold KR: Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch Dermatol 2001;137:1079-1081. (Pubitemid 32756467)
82. Elias PM, Wood LC, Feingold KR: Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat 1999;10:119-126. (Pubitemid 29416060)
83. Elias PM, Hatano Y, Williams ML: Basis for the barrier abnormality in atopic dermatitis: outsideinside- outside pathogenic mechanisms. J Allergy Clin Immunol 2008;121:1337-1343.
84. Lomholt H, Andersen KE, Kilian M: Staphylococcus aureus clonal dynamics and virulence factors in children with atopic dermatitis. J Invest Dermatol 2005;125:977-982.
85. Hasannejad H, Takahashi R, Kimishima M, Hayakawa K, Shiohara T: Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis. J Allergy Clin Immunol 2007;120:69-75. (Pubitemid 46990500)
86. McGirt LY, Beck LA: Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 2006;118: 202-208. (Pubitemid 43946481)
87. Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, Heeg K, Neumaier M, Renz H: The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004;113:565-567. (Pubitemid 38338967)
88. Mrabet-Dahbi S, Dalpke AH, Niebuhr M, Frey M, Draing C, Brand S, Heeg K, Werfel T, Renz H: The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol 2008;121:1013-1019.
89. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung DY, Lipozencic J, Luger TA, Muraro A, Novak N, Platts-Mills TA, Rosenwasser L, Scheynius A, Simons FE, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T: Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006;61:969-987. (Pubitemid 44024897)
90. Schimming TT, Parwez Q, Petrasch-Parwez E, Nothnagel M, Epplen JT, Hoffjan S: Association of Toll-interacting protein gene polymorphisms with atopic dermatitis. BMC Dermatol 2007;7:3.
91. Sugarman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL, Williams ML: The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol 2003; 139:1417-1422. (Pubitemid 37433131)
92. Seidenari S, Giusti G: Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 1995;75:429-433. (Pubitemid 26051887)
93. Chamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW, Williams ML, Elias PM: Ceramidedominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002;47:198-208.
94. Elias PM: The skin barrier as an innate immune element. Semin Immunopathol 2007;29:3-14. (Pubitemid 47596384)
95. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347: 1151-1160.
96. Rieg S, Steffen H, Seeber S, Humeny A, Kalbacher H, Dietz K, Garbe C, Schittek B: Deficiency of dermcidin- derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 2005;174:8003-8010. (Pubitemid 40806311)
97. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R: IL-22 increases the innate immunity of tissues. Immunity 2004;21:241-254. (Pubitemid 39094053)
98. De Jongh GJ, Zeeuwen PL, Kucharekova M, Pfundt R, van der Valk PG, Blokx W, Dogan A, Hiemstra PS, van de Kerkhof PC, Schalkwijk J: High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 2005;125:1163-1173.
99. Howell MD, Wollenberg A, Gallo RL, Flaig M, Streib JE, Wong C, Pavicic T, Boguniewicz M, Leung DY: Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 2006;117: 836-841.
100. Howell MD, Novak N, Bieber T, Pastore S, Girolomoni G, Boguniewicz M, Streib J, Wong C, Gallo RL, Leung DY: Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 2005;125:738-745.
101. Jeong CW, Ahn KS, Rho NK, Park YD, Lee DY, Lee JH, Lee ES, Yang JM: Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs extrinsic atopic dermatitis patients using semiquantitative RT-PCR. Clin Exp Allergy 2003;33: 1717-1724.
102. Homey B, Steinhoff M, Ruzicka T, Leung DY: Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006;118: 178-189. (Pubitemid 43946487)
103. Grewe M, Gyufko K, Schopf E, Krutmann J: Lesional expression of interferon-gamma in atopic eczema. Lancet 1994;343:25-26.
104. Leung DY, Bieber T: Atopic dermatitis. Lancet 2003; 361:151-160. (Pubitemid 36092023)
105. Gambichler T, Skrygan M, Tomi NS, Othlinghaus N, Brockmeyer NH, Altmeyer P, Kreuter A: Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 2008;147:17-24.
106. Asano S, Ichikawa Y, Kumagai T, Kawashima M, Imokawa G: Microanalysis of an antimicrobial peptide, beta-defensin-2, in the stratum corneum from patients with atopic dermatitis. Br J Dermatol 2008;159:97-104. (Pubitemid 351874497)
107. Jansen PA, Rodijk-Olthuis D, Hollox EJ, Kamsteeg M, Tjabringa GS, de Jongh GJ, van Vlijmen-Willems IM, Bergboer JG, van Rossum MM, de Jong EM, den Heijer M, Evers AW, Bergers M, Armour JA, Zeeuwen PL, Schalkwijk J: Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. PLoS One 2009;4:e4725.
108. Harder J, Dressel S, Wittersheim M, Cordes J, Meyer-Hoffert U, Mrowietz U, Folster-Holst R, Proksch E, Schroder JM, Schwarz T, Glaser R: Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 2010;130:1355-1364.
109. Ballardini N, Johansson C, Lilja G, Lindh M, Linde Y, Scheynius A, Agerberth B: Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema. Br J Dermatol 2009; 161:40-47.
110. Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, Udall D, Kanada K, Yamasaki K, Alexandrescu D, Gallo RL: Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 2008;122:829-831.
111. Buchau AS, Macleod DT, Morizane S, Kotol PF, Hata T, Gallo RL: Bcl-3 acts as an innate immune modulator by controlling antimicrobial responses in keratinocytes. J Invest Dermatol 2009;129:2148-2155.
112. Higaki S, Morohashi M, Yamagishi T, Hasegawa Y: Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol 1999;38:265-269. (Pubitemid 29189630)